Retinal neovascularization is a severe complication of proliferative diabetic retinopathy. MicroRNAs (miRNAs) are master regulators of gene expression that play important roles in retinal neovascularization. Here, we investigated the retinal miRNA expression profile in a rat model of oxygen-induced retinopathy (OIR) through miRNA-Seq. We found that miR-143-3p, miR-126-3p, miR-150-5p and miR-145-5p were significantly down-regulated in the retina of OIR rats, and directly involved in the development of retinal neovascularization. Of these identified miRNAs, miR-143 is enriched in retina and was first reported being associated with pathological retinal angiogenesis. Our RNA-Seq data further suggested that miR-143 alleviates retinal neovascularization by mediating the inflammation/stress pathways via Fos. Moreover, the computational analysis indicated that Transforming Growth Factor-beta Activated Kinase 1 (TAK1) is involved in several key pathways associated with the dysregulated miRNAs. The pharmacological inhibition of TAK1 suppressed angiogenesis in vitro and retinal neovascularization in vivo. Our data highlight the utility of next-generation sequencing in the development of therapeutics for ocular neovascularization and further suggest that therapeutic targeting the dysregulated miRNAs or TAK1 may be a feasible adjunct therapeutic approach in patients with retinal neovascularization.
Introduction
Retinal neovascularization is a sight-threatening sequela of several common diseases, including proliferative diabetic retinopathy (1) . The development of abnormal, new blood vessels may lead to serious complications that cause vision loss and blindness, such as vitreous hemorrhage and retinal detachment. Although the increased understanding of the pathogenesis of retinal angiogenesis has led to the development of effective treatments, most notably vascular endothelial growth factor (VEGF) inhibitors, certain patients respond poorly to treatment, indicating that other pathways may be involved. Furthermore, the cost-effectiveness of the prolonged use of VEGF inhibitors (e.g., ranibizumab and aflibercept) may have deleterious consequences (2) . Thus, novel therapeutic options for patients with retinal neovascularization are needed.
MicroRNAs (miRNAs) constitute a class of endogenous non-coding RNA molecules of approximately 22 nucleotides in length. miRNAs act by complementary base pairing at the 3' untranslated region (3' UTR) of target mRNA, resulting in the degradation or translational repression of the target mRNA (3) . miRNAs play important roles in several biological processes, including cellular growth, development, differentiation, homeostasis, and death (4) . A single miRNA typically has hundreds of potential target mRNAs, and conversely, a single mRNA may be targeted by multiple miRNAs (3) . miRNAs have been shown to be important modulators of blood vessel formation and function. The dysregulation of retinal miRNAs, such as miRNA-150 (miR-150), miRNA-126 (miR-126), and miRNA-155 (miR-155), may cause the progression of retinal neovascularization in animal models (5) (6) (7) . However, these studies have yielded inconsistent results, which are likely due to different protocols of establishing animal models. Moreover, the potential of using these dysregulating miRNAs as a treatment for retinal neovascularization is unclear.
In this study, we performed next-generation sequencing (NGS) to identify the dysregulated miRNAs in a rat model of oxygen-induced retinopathy (OIR) (Fig. 1A) . Next, we evaluated the involvement of these dysregulated miRNAs in the development of retinal neovascularization in the OIR rats (Fig. 1B) . Finally, we interrogated the putative functions of the dysregulated miRNAs through the in-silico analysis and identified transforming Growth Factor-beta Activated Kinase 1 (TAK1), which is a serine/threonine kinase, was involved in retinal neovascularization. Selective inhibition of TAK1 by 5Z-7-oxozeaenol was showed to suppress angiogenesis in vitro and in vivo (Fig. 1C) . Our study highlights the utility of computational analyses using NGS data in screening for novel genes involved in complex pathological processes, such as retinal neovascularization. OIR rat model and vessel quantification. OIR was induced as previously described (43) . Briefly, newborn Sprague-Dawley rats and their nursing mothers were housed in custom-built, humidified chambers within 12 hours of birth (postnatal day 0, P0) and exposed to daily cycles of 80% O 2 for 21 hours and room air for 3 hours from P0 to 14. The pups were then returned to room air until P18. An oxygen controller (PROOX 110; BioSpherix, Parish, NY, USA) was used to monitor and control the oxygen level. The rats were sacrificed at P18, and their retinas were dissected and stained with isolectin B 4 (5 g/mL, Alexa Fluor 488, catalogue no. I21411; Life Technologies Australia, Mulgrave, VIC, Australia). The neovascularization and vaso-obliteration in the rat retinas were quantified using Adobe Photoshop (CC 2017.1.1) (44) . The quantification and analysis were performed by two blinded assessors (JHW and LT).
Materials and Methods

Animals
Extraction of RNA and qPCR. Total RNA and miRNA were isolated from the dissected retinas using miRNeasy mini kits (catalogue no. 217084; Qiagen, Chadstone, VIC, Australia). Quantitative PCR was performed using a StepOne™ Real-Time PCR System (Applied Biosystems, Foster City, CA, USA). The methods used are further described in Supplementary information. Detailed information regarding the qPCR assays is provided in Supplementary Table 1 .
MicroRNA and RNA next-generation sequencing. The microRNA and RNA next-generation sequencing was performed following established protocols (45; 46) . Additional information is provided in Supplementary information.
Computational analysis.
To explore the miRNA regulatory network, we analyzed the putative target genes of the dysregulated miRNAs (i.e., miR-150-5p, miR-126-3p, miR-143-3p and miR-145-5p) that were validated by qPCR using Ingenuity Pathways Analysis 2016 (IPA 2016, Ingenuity System, http://www.ingenuity.com) and the core analysis method tool. The putative target genes of the down-regulated miRNAs were obtained from multiple online databases, including miRNA.org and IPA. All putative target genes were merged and entered into IPA for the core analysis. IPA analysis identified the canonical pathways related to the target genes of the down-regulated miRNAs by Fisher's exact test and adjusted P-values<0.05. To reduce the range of target genes, the target genes in each selected signaling pathway were matched to the Gene Ontology-derived gene set (47) of angiogenesis (http://amigo.geneontology.org/amigo/term/GO:0001525). Thus, the angiogenic genes shared by several pathways were identified. IPA and core analysis were also applied to analyze the regulatory network of the genes selected from the RNA-Seq. To explore the functional properties of these identified genes, the STRING search tool (http://www.string-db.org/) was used to create protein-protein interaction networks and reveal the interactivity of these gene products. 
Intravitreal injection.
Electroretinography (ERG).
A low dose (18 ng) of 5Z-7-Oxozeaenol or vehicle was injected intravitreally into the eyes of male Brown Norway rats; 28 days following the injection, the rats underwent ERG. The details of the functional assessment are described in Supplementary information.
Optical coherence tomography (OCT)
Following the ERG measurement, the rat eyes were imaged using spectral domain-OCT. The details of this procedure are described in Supplementary information.
Aortic ring sprouting assay. Aortic ring assays were performed following an established protocol (50) . The aortae were isolated from C57BL/6 mice, sectioned into 1-mm-long rings, and cultured in Matrigel. The rings were imaged daily, and the sprouting area was quantified. Further information is provided in Supplementary information.
Data availability
The retinal miRNA profiles of the rats and mice and retinal miRNA transcriptomes from the rat model of OIR by next-generation sequencing have been deposited in NCBI's Gene Expression Omnibus and are accessible through GEO Series accession number GSE104593 
Results
Retinal microRNA expression is significantly down-regulated in the OIR rats
Given mouse and rat models of OIR are commonly used for studying retinal neovascularization, we sought to identify which of the two species gives a higher degree of homology in retinal miRNA expression profile to human. Using miRNA-sequencing (miRN-Seq) by NGS, we found that under control conditions, both rats and mice shared ~63.0% of human retinal miRNAs (8) ( Supplementary   Fig. 1A ). By aligning the average read count of retinal miRNAs of rat or mouse with top 100 miRNAs expressed in the human retina (8), these miRNAs were found to be highly conserved between rat and mouse ( Supplementary Fig. 1B ). Therefore, we chose the rat model for our subsequent studies because the development of retinal neovascularization in the rats with OIR better reflects human retinopathy of prematurity (9; 10).
The OIR rat model involves exposing rat pups to daily cycles of 80% O 2 for 21 hours and room air for 3 hours from postnatal day (P) 0 to P14. At P14, the rat pups are returned to a relatively hypoxic environment (room air), which results in pathologic neovascularization at P18 and regression of neovascularization by P29 ( Fig. 2A) . MicroRNA-Seq was performed to obtain an overall picture of the miRNA expression profile in the retinas of OIR rats and age-matched normoxic (housed in room air) rats at P14. A ranking of the identified miRNAs in the retina from normoxic rats based on the read count of each miRNA was listed in Supplemental Data 1. Seven miRNAs (miR-451-5p, miR-150-5p, miR-126-3p, miR-126-5p, miR-143-3p, miR-145-5p and miR-145-3p) were found to be down-regulated by the OIR with a Log2 (Fold Change) less than -1 and adjusted p value less than 0.05 compared to the normoxia (Table 1) . Moreover, several miRNAs were upregulated but without statistical significance (adjusted p > 0.05) in the retinas from rats with OIR ( Fig. 2B and 2C ).
Of those down-regulated miRNAs, we selected five miRNAs with mature miRNA strands for further analysis, which included miR-451-5p, miR-150-5p, miR-126-3p, miR-143-3p and miR-145-5p. Most importantly, these down-regulated miRNAs in the OIR rats at P14 were restored at P29 when the cyclic oxygen exposed neonatal rats were returned to room air for 15 days (Supplementary Table 3 ).
To validate the changes in the identified miRNAs, total retinal miRNA was isolated from an additional two cohorts of OIR and normoxic rats, and the miRNA expression was evaluated by performing quantitative PCR (qPCR). The expression profiles of miR-150-5p, miR-126-3p, miR-143-3p and miR-145-5p ( Fig. 2D ) were similar to those identified in the miRNA-Seq; however, the expression of miR-451-5p was lower and more variable in the OIR rats, and thus it was excluded from further analysis.
MicroRNA treatment attenuates retinal neovascularization
To validate the involvement of the endogenous miRNA down-regulation in OIR rats, we quantified the effects of intravitreal injection of synthetic miR-143, miR-126, miR-150 and miR-145 mimics on retinal neovascularization at P14 (Fig. 3A) . Four days after injection, retinal neovascularization was significantly attenuated in the OIR rats receiving a single intravitreal injection of synthetic miR-143, miR-126 or miR-150 mimics. However, no benefit was found in the OIR rats receiving miR-145 mimics ( Fig. 3B, 3C and Supplementary Fig. 2 ). Moreover, no statistical difference was found in the vaso-obliteration (avascular area) between the rats receiving miRNA mimics and scramble RNAs in each group ( Fig. 3D and Supplementary Fig. 2 ).
MicroRNA-143 suppresses retinal neovascularization via inflammation/stress-related pathways
Since miR-143 is highly enriched in the normal human retina and the role of miR-143 has never been explored, we sought to explore the underlying mechanism by which miR-143 attenuates retinal neovascularization in OIR rats. Neonatal pups subjected to either normoxia or OIR for 14 days (P14)
were received an intravitreal injection of either scrambled miRNAs (control) or miR-143 mimics, and the retinas of rats were dissected at P18. Total RNAs were isolated from the retinas and subjected to RNA-Seq ( Table 2 ). We also found that the expression levels of these genes were either reduced or increased in the OIR rats receiving miR-143 mimics compared to the OIR rats receiving scrambled RNAs. Notably, none of the identified genes was established as direct targets of miR-143 in the miRBase (http://www.mirbase.org/) or TargetScan Fig. 3 ).
Identification of TAK1 as a potential therapeutic target in OIR
To interrogate the putative functions of the down-regulated miRNAs (miR-143-3p, miR-126-3p, miR-150-5p and miR-145-5p) in the OIR rats, implicated target genes of individual miRNA were predicted using online databases including miRNA.org and Ingenuity Pathways Analysis (IPA), and were subjected to a canonical pathway analysis. A total of 2,763 target genes involved in 38 different biological processes or cellular functions were identified (Fig. 5A) . Three pathways associated with angiogenesis and diabetic retinopathy (11; 12) were identified, including molecular mechanisms of cancer and the transforming growth factor-beta (TGF-β) and AMP-activated protein kinase (AMPK) signaling pathways. To further refine the list of putative target genes, filters for the overlapping target genes involved in each signaling pathway and Gene Ontology-derived angiogenic gene set were applied. TAK1 was identified as the sole pro-angiogenic gene involved in all three pathways (Fig. 5B ). This gene is regulated by miR-143-3p. Other pro-angiogenic genes regulated by miR-143-3p, miR-126-3p, and miR-150-5p were also predicted ( Supplementary Fig. 4 ).
A qPCR analysis was conducted to validate the retinal mRNA expression of TAK1 in the retina of OIR rats. The TAK1 mRNA expression was significantly increased in the OIR rats at P14 but normalized at P29 relative to the normoxic rats (Fig. 5C ). The increased TAK1 mRNA expression in the OIR rats at P14 was likely associated with the decreased expression of miR-143 as TAK1 is negatively regulated by miR-143. To examine the regulatory effect of miR-143-3p on TAK1 expression, we co-transfected a reporter vector encoding the firefly luciferase gene, followed by the miR-143-3p target sequence from the 3' UTR of TAK1 gene, along with a synthetic miR-143 mimic into HEK293A cells. The luciferase activity was markedly suppressed in the cells transfected with the reporter vectors containing the target sequences of TAK1 (Fig. 5D, 5E and Supplementary Table   4 ). These results suggested that miR-143 directly regulates the expression of TAK1, at least in part, at the post-transcriptional level through targeting the 3'UTR target sequence of TAK1 gene.
Pharmacological inhibition of TAK1 suppresses angiogenesis in vitro and ex vivo and retinal neovascularization in vivo
Subsequently, we sought to validate the effect of TAK1 inhibition on angiogenic processes in vitro.
We investigated the effect of a commercially available TAK1 inhibitor, 5Z-7-Oxozeaenol, on angiogenesis in human umbilical vein endothelial cells (HUVECs). Compared with cells treated with the vehicle alone, cell proliferation was significantly inhibited (18.7% and 46.1% reduction at 24 and 48 hours, respectively) in the presence of 1000 nM 5Z-7-Oxozeaenol (Fig. 6A) . The cells treated with 5Z-7-Oxozeaenol showed reduced migration in the scratch migration assay (63.2% reduction, Oxozeaenol showed a significant (56.2%) reduction in branching compared with the vehicle-treated cells (Fig. 6C) . Nine days of treatment with 5Z-7-Oxozeaenol also suppressed vascular sprouting from aortic ring explants isolated from C57BL/6 mice (45.8% reduction, Fig. 6D ). Altogether, these in vitro and ex vivo data indicate that the inhibition of TAK1 suppresses angiogenic activity.
To further examine the effect of TAK1 inhibition on retinal neovascularization, 5Z-7-Oxozeaenol was administered to the OIR rats via intravitreal injection at P14. The extent of neovascularization was quantified at P18 (Fig. 6E) . A significant reduction in retinal neovascularization was observed in the OIR rats receiving either a low (18 ng/eye) or high (90 ng/eye) dose of 5Z-7-Oxozeaenol (50.0% and 53.3% reduction, respectively) compared with those receiving vehicle alone (Fig. 6F, 6G and Supplementary Fig. 5 ). No significant difference in vasoobliteration was found among the three groups (Fig. 6H) . We also evaluated whether 5Z-7-Oxozeaenol is toxic to the rodent retinas. Electroretinography (ERG) and optical coherence tomography (OCT) were performed to examine retinal functioning and structure 28 days after intravitreal injections of low-dose 5Z-7-Oxozeaenol in pigmented Brown Norway rats. No significant difference was observed in retinal function (Fig. 7A-D) or thickness ( Fig. 7E-I ) between the 5Z-7-Oxozeaenol and vehicle-treated eyes.
Discussion
MicroRNAs have been implicated in several in vitro and in vivo studies as crucial regulators of organ development and homeostasis (13) . Many studies conducted over the previous decade suggest that abnormalities in miRNAs are involved in a range of disease processes, such as retinal neovascularization (14) . Using miRNA-Seq, we identified four miRNAs including miR-143-3p, miR-126-3p, miR-150-5p and miR-145-5p were down-regulated in the retinas of rats subjected to ischemia-induced retinal angiogenesis. Of these down-regulated miRNA, miR-143-3p, miR-126-3p
and miR-150-5p were directly contributed to the development of retinal neovascularization in OIR rats. Notably, our study provided the first evidence that dysregulation of miR-143 is involved in pathological retinal angiogenesis, and we also revealed that miR-143 alleviates retinal neovascularization by modulating the inflammation/stress pathway via Fos by RNA-Seq. Moreover, in silico analyses of miRNA-Seq data identified that TAK1 as a novel mediator involved in ischemia-induced retinal angiogenesis. The selective inhibition of TAK1 using 5Z-7-Oxozeaenol suppressed retinal neovascularization. Our data suggest that dysregulation of miRNAs is involved in the pathogenesis of retinal angiogenesis. Targeting the dysregulated miRNAs or inhibiting TAK1 may be a feasible adjunct therapeutic approach in patients with retinal neovascularization.
Profiling miRNA expression in human specimens is an emerging approach to characterize diseases and identify novel biomarkers or therapeutic targets for diagnosis and treatment (15; 16).
Unlike those tissues that are relatively accessible for biopsy, human retina is difficult to sample for analysis. Therefore, animal models are commonly used to investigate the roles of miRNAs in retinal neovascularization. The rodent OIR model is widely adopted to study the pathogenesis of ischemiainduced retinal angiogenesis or to test novel therapies for retinal neovascularization. Recently, a few studies investigated retinal miRNA expression in OIR mice using microarray-based platform and showed changes in retinal miRNA expression that being associated with retinal neovascularization (17) (18) (19) . miRNA-Seq can provide absolute miRNA quantification with high accuracy and sensitivity compared with microarray assays (20; 21). Using miRNA-Seq, we have shown that the miRNA expression profile in the rat retina is comparable to that in the mouse retina. In addition, we identified that several miRNAs were differentially expressed following oxygen exposure in the retinas of OIR rats.
Previous miRNA profiling studies have identified several down-regulated miRNAs in the retinas of OIR mice, including miR-150, miR-375, miR-129-5p, and miR-129-3p (17; 18). In the present study, miR-143-3p, miR-126-3p, miR-150-5p and miR-145-5p were down-regulated in the OIR rats at P14 compared with those in the normoxic rats. This discrepancy may reflect differences in the tissue-specific expression of miRNAs across species (22) . It has been reported that miR-143 is down-regulated in diseases associated with angiogenesis particularly in cancers, such as colon and lung cancers (27) .
Indeed, a study found that over-expression of miR-143 decreased tumor growth and angiogenesis, putatively by targeting and inhibiting the NRAS, which is a RAS family oncogene (28 
Intravitreal injection of miR-143 mimics may normalize aberrant expression of Fos-and
Cryaa-mediated genes, and thus result in the suppression of retinal neovascularization in OIR rats.
Cryaa is a lens-abundant gene (30) and plays important roles in maintaining lens transparency (31) . In summary, this study demonstrates that miR-150-5p, miR-126-3p, miR-143-3p, and miR-145-5p are down-regulated in the retina of rats with proliferative retinopathy. Furthermore, we show that the retina-enriched miR-143 plays a protective role in retinal neovascularization via Fos.
Selectively antagonizing the activity of TAK1 by 5Z-7-Oxozeaenol suppresses pro-angiogenic pathways and reduces retinal neovascularization. These findings highlight the utility of computational analyses using NGS data in screening for novel genes involved in complex pathological processes, such as retinal neovascularization. Moreover, the identification of novel genes allows for the identification of therapeutic targets, potential pharmacological agents, and new therapeutic approaches. Tables   Tables  Table 1 . MicroRNAs are significantly down-regulated in the OIR rats at P14 compared to the normoxic rats. Schematic diagram of establishment of the OIR rat model. Neonatal rats were exposed to a daily cycle of 80% oxygen for 21 hours and room air for 3 hours from postnatal day (P) 0 to P14 and subsequently returned to room air. Retinal vaso-obliteration and neovascularization were observed in the OIR rats at P14 and P18, respectively. Retinal neovascularization was completely regressed, and the vasculature was fully normalized in the OIR rats at P29 (A). Total RNA, including miRNAs, was isolated from the retinas of OIR rats and age-matched normoxic rats at P14 and subsequently subjected to miRNA-Seq. The results are representative of three biological replicates (retinas) from one littermate. A volcano plot illustrates each miRNA with Log2 (Fold Change) (OIR versus normoxia) and p value (-Log10 (P-value) converted, e.g. -Log10 (0.05) = 1.3). Of 466 miRNAs, 7 were down-regulated with Log2 (Fold Change) less than -1 in the OIR rats compared to the normoxic rats. Of 7 miRNAs, miRNAs with mature form including miR-143-3p, miR-150-5p, miR-126-3p and miR-145-5p, were subjected to qPCR validation (B). A heat map illustrating the miRNAs that were significantly down-regulated in the retina of the OIR rats at P14 as analyzed by miRNASeq. Red indicates up-regulated expression levels; green indicates down-regulated expression levels. (C) Expression of retinal miR-150-5p, miR-126-3p, miR-143-3p, and miR-145-5p was suppressed in the OIR rats compared with those in the normoxic rats at P14 as analyzed by qPCR (D). All data were normalized to U6 small nuclear RNA. The results are representative of three biological replicates (retinas) from another littermate and expressed as the mean ± s.e.m. . TAK1 mRNA was significantly up-regulated in the retina of OIR rats at P14 compared with that in the normoxic rats as analyzed by qPCR. The results are representative of twelve and eleven independent biological replicates (retinas, three different littermates per group) from the normoxic and OIR groups, respectively. Data are expressed as the mean ± s.e.m Two-tailed Student's t-test was performed to determine the significant difference (C). The diagram of reporter vectors that encoding firefly luciferase with or without miR-143 responding elements from 3'-UTR of TAK1 gene (pCMV_Luciferase/miRE or pCMV_Luciferase). UTR: untranslated region. miRE: miRNA response elements. The expression levels of firefly luciferase were suppressed in HEK293A cells that co-transfected the reporter vector containing the target sequence of TAK1 along with the miR-143 mimics. The results are representative of four independent biological replicates from two experiments and are expressed as the mean±s.e.m. Twoway ANOVA, followed by Tukey's test, was performed to determine the significance of the differences (P=0.0006 for the interaction, P=0.0033 for treatment, P<0.0001 for plasmids; **P<0.005) (D). HUVECs treated with 1000 nM 5Z-7-Oxozeaenol had a lower proliferative capability after 24 hours and 48 hours. Two-way ANOVA, followed by Tukey's test, was performed to determine the significance of the differences (P<0.0001 for the interaction, P<0.0001 for concentration, 
